Heron Therapeutics Inc
NASDAQ:HRTX 4:00:00 PM EDT
Market Cap (Intraday) | 416.41M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $2.83 |
50-Day MA | $2.72 |
200-Day MA | $1.74 |
Heron Therapeutics Inc Stock, NASDAQ:HRTX
4242 Campus Point Court, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.251.4400
Number of Employees: 126
Description
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.